期刊文献+

BNP、MCP-1对不稳定型心绞痛近期预后判断的价值 被引量:9

The value of plasma BNP and MCP-1 levels for short-term prognosis of UA without heart failure
下载PDF
导出
摘要 目的:探讨血浆B型钠尿肽(brain natriuretic peptide,BNP)、单核细胞趋化蛋白-1(monocyte chemoattractant protein-1,MCP-1)水平对不稳定型心绞痛(unstable angina,UA)近期预后判断的价值。方法:按Braunwald标准,85例心功能正常的UA患者分为ⅠB组(25例)、ⅡB组(30例)及ⅢB组(30例),并取20例稳定型心绞痛(SAP)患者作为对照组。入院后24h内抽肘前静脉血,分别行BNP和MCP-1检测。随访30天内主要不良心脏事件(MACE)。结果:UA组BNP及MCP-1均显著高于对照组(P均<0.05);ⅢB组显著高于ⅠB组和ⅡB组(P均<0.05)。冠状动脉3支与2支病变组BNP明显高于单支病变组(P均<0.05);3支病变组MCP-1明显高于2支及单支病变组(P均<0.05)。Logistic回归分析显示BNP和MCP-1是30天MACE的独立预测因素。结论:血浆BNP、MCP-1水平对心功能正常的UA近期不良预后的评估具有重要意义。 Objective:To evaluate the early prognostic role of plasma brain natriuretic peptide(BNP)and monocyte chemoattractant protein-1(MCP-1)levels in patients with unstable angina(UA). Methods:Eighty-five cases UA without heart failure were divided into IB (n=25),IIB(n=30)and IIIB(n=30)groups according to Braunwald classification, and 20 cases stable angina pectoris(SAP)were chosen in the control group. Plasma samples for BNP and MCP-1 were obtained in the first 24 h. The incidences of main abnormal cardiac event (MACE)were recorded during 30 days. Results:In every UA groups,plasma levels of BNP and MCP-1 elevated significantly, and in comparison to those in the control group,there were statistically significant difference(all P〈0.05). Plasma levels of BNP and MCP-1 in IIIB group were higher than those in IIB group and IB group (all P〈0.05). The levels of BNP and MCP-1 were significantly higher in patients who had complex lesions compared with those who had simple lesions (P〈0.05). Multivariable logistic regression analysis revealed that BNP and MCP-1 were all risk factors for cardiac events (all P〈0.05). Conclusion:Measurement of BNP and MCP-1 are helpful in predicting the short-term prognosis in UA patients without heart failure.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2010年第3期405-408,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省"六大高峰人才"基金资助项目(2006075)
关键词 UA BNP MCP-1 预后 unstable angina(UA) brain natriuretic peptide(BNP) monocyte chemoattractant protein-1 (MCP-1) prognosis
  • 相关文献

参考文献15

  • 1Weber M,Bazzino O,Navarro Estrada JL,et al. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coro- nary syndromes and normal troponin T values upon admission[J]. J Am Coil Cardiol,2008,51 (12) : 1188-1195. 被引量:1
  • 2de Lemos JA, Morrow DA, Blazing MA,et al. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes:results from the A to Z trial[J]. Am J Cardiol, 2007,50(27) : 2117-2124. 被引量:1
  • 3Morrow DA,de Lemos JA,Blazing MA,et al. Prognostic value of serial B-type natriuretie peptide testing during follow-up of patients with unstable coronary artery disease [J]. JAMA, 2005,294(22) : 2866-2871. 被引量:1
  • 4Palazzuoli A, Deckers J, Calabro A, et al. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function [J]. Am J Cardiol,2006,98 (10) : 1322-1328. 被引量:1
  • 5Sinclair H,Paterson M,Walker S,et al. Predicting outcome in patients with acute coronary syndrome:evalua- tion of B-type natriuretic peptide and the global registry of acute coronary events (GRACE)risk score [J].Scott Med J,2007,52(3) :8-13. 被引量:1
  • 6de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes [J]. N Engl J Med,2001,345 (lg) : 1014-1021. 被引量:1
  • 7Sabatine MS,Morrow DA,de Lemos JA,et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia [J], J Am Coll Cardiol, 2004,44(10) : 1988-1995. 被引量:1
  • 8Asada J,Tsuji H,Iwasaka T,et al. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine- induced myocardial ischemia [J].Am J Cardiol,2004,93 (6) :702-704. 被引量:1
  • 9Aylin Y, Sadik A,Cagatay E, et al. Effects of lesion complexity on baseline and postprocedural B-type natriuretic peptide levels in patients undergoing percutaneous coronary interventions [J]. Tex Heart Inst J,2007,34 (3): 282-289. 被引量:1
  • 10Palazzuoli A,Gennari L,Calabira P,et al. Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries [J]. Am J Cardiol, 2005,96(12) : 1705-1710. 被引量:1

二级参考文献13

  • 1J Am Coll Cardiol,张伟丽.CRP与斑块破裂有关[J].中国分子心脏病学杂志,2005,5(3):546-546. 被引量:78
  • 2庄瑜,陈鑫,石开虎,徐明.AMI大鼠心肌组织中SDF-1与MCP-1动态变化及意义[J].山东医药,2007,47(2):7-10. 被引量:4
  • 3Falk E, Shah PK, Fuster V. Coronary plaque disruption[ J]. Circulation, 1995, 92(3) :657 -671. 被引量:1
  • 4Dollery CM, McEwan JR, Henney AM. Matrixmetallop roteases and cardiovascular disease [ J ]. Circ Res, 1995, 77 ( 5 ) : 863 - 868. 被引量:1
  • 5Ross R. Atherosclerosis-an inflammatory disease [ J ]. N Engl J Med, 1999, 340(2) :115 -126. 被引量:1
  • 6Suzuki T, Yamazaki T, Yazaki Y, et al. The role of the natriuretic peptidein the cardiovascular system [ J ]. Cardiovasc Res, 2001, 51 (3) :489 - 494. 被引量:1
  • 7Asada J, Tsuji H, lwasaka T, et al. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemial[ J]. Am J Cardiol, 2004, 93(6) :702 -704. 被引量:1
  • 8Morrow DA, Braunwald E. Future of biomarkers in acute coronary syndromes : moving toward a multimarker strategy [ J ]. Circulation, 2003, 108(3) :250 -252. 被引量:1
  • 9Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretie peptide in patients with acute myocardial infarction [J]. Circulation, 1993, 88( 1 ) :82 -91. 被引量:1
  • 10de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes[J]. N Engl J Med, 2001, 345(14) :1014 - 1021. 被引量:1

共引文献57

同被引文献95

引证文献9

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部